Dostarlimab-gxly (Jemperli)
Dilution requiredFull monograph review pending
U.S. label preparation
Jemperli · Dilution required
- Preparation
- Use 0.9% sodium chloride or 5% dextrose. For 500 mg, target 2-10 mg/mL. For 1,000 mg, target 4-10 mg/mL. Maximum prepared volume is 250 mL.
- Administration and handling
- Infuse over 30 minutes through the labeled low-protein-binding 0.2-micron filter.
Product and source details
GlaxoSmithKline LLC · BLA761174
Product NDC: 0173-0898
SPL effective 2026-10-19 | SPL version 15. Checked 2026-11-13.
Source for this summary: U.S. prescribing information. Use the full label for dose selection, contraindications, preparation tables and monitoring.
Product identifiers and clinical review status
U.S. label preparation available. Full monograph review pending.
Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.
What remains to be completed
- Obtain independent corroboration of the label preparation where available.
- Complete indication- and age-specific dosing, incompatibility, monitoring and stability review.
- Assess any proposed compounding BUD for the exact formulation, concentration, container and conditions.